Effects of a new hypolipidemic agents, MK-185, on serum thyroxine-binding globulin (TBG) and dialyzable fraction thyroxine.
D000818:Animals; D001665:Binding Sites; D001797:Blood Protein Electrophoresis; D002247:Carbon Isotopes; D002417:Cattle; D003956:Dialysis; D006016:Glycolates / Q000494:pharmacology*; D006801:Humans; D006949:Hyperlipidemias / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007456:Iodine Isotopes; D011485:Protein Binding / Q000187:drug effects*; D012709:Serum Albumin / Q000378:metabolism; D013974:Thyroxine / Q000097:blood*; D013975:Thyroxine-Binding Proteins / Q000097:blood*
D002247:Carbon Isotopes; D006016:Glycolates; D000960:Hypolipidemic Agents; D007456:Iodine Isotopes; D012709:Serum Albumin; D013975:Thyroxine-Binding Proteins; D013974:Thyroxine